Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunogenicity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01974895
What this trial is testing

Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine GSK2282512A When Administered to Children From 6 to 35 Months of Age

Who this might be right for
Influenza
GlaxoSmithKline 316
Post-approval studies (Phase 4)Study completedNCT01355172
What this trial is testing

Immunogenicity and Safety of AdimFlu-S, Formulation 2010-2011, in Infants Aged Between 6-12months Old

Who this might be right for
Influenza
Adimmune Corporation 59
Early research (Phase 1)WithdrawnNCT05609045
What this trial is testing

A Phase 1, Randomised, Double-blinded, Placebo-controlled, Dose-escalation Study to Evaluate the Safety and Immunogenicity of RH109 as Booster

Who this might be right for
COVID-19 Pandemic
Wuhan Rhegen Biotechnology Co., Ltd.
Large-scale testing (Phase 3)Study completedNCT02003703
What this trial is testing

Comparative Efficacy of an Intensified Re-vaccination Scheme for Hepatitis B Virus Infection Among Patients Infected With HIV .

Who this might be right for
Hepatitis BHIV
Universidad de Valparaiso 107
Early research (Phase 1)Study completedNCT00053742
What this trial is testing

Phase I/II Trial of Modified Vaccinia Virus Ankara (MVA) Vaccine Against Smallpox

Who this might be right for
Healthy
National Institute of Allergy and Infectious Diseases (NIAID) 80
Large-scale testing (Phase 3)UnknownNCT05015686
What this trial is testing

Safety and Immunogenicity of Live Attenuated Varicella Vaccine in Healthy Population Aged ≥13 Years Old

Who this might be right for
Varicella
Sinovac (Dalian) Vaccine Technology Co., Ltd. 2,400
Large-scale testing (Phase 3)Study completedNCT05338086
What this trial is testing

Compare Efficacy, PK, PD, Safety and IMM of MB09 to Prolia® [EU-sourced] in Postmenopausal Osteoporosis.

Who this might be right for
Postmenopausal Women With Osteoporosis
mAbxience Research S.L. 558
Post-approval studies (Phase 4)UnknownNCT04270773
What this trial is testing

Immunogenicity and Safety of a 9-valent Human Papillomavirus Vaccine in HIV-positive Women

Who this might be right for
HIV InfectionsHPV Infection
University Hospital Virgen de las Nieves 158
Large-scale testing (Phase 3)WithdrawnNCT04990466
What this trial is testing

Phase 2b/3 Trial of VSV-ΔG SARS-CoV-2 Vaccine (BRILIFE) Against Approved Comparator Vaccine.

Who this might be right for
COVID-19
NeuroRx, Inc.
Early research (Phase 1)Study completedNCT01364883
What this trial is testing

Safety and Immunogenicity of Novel Vaccination Schedules With Malaria Vaccines AdCh63 ME-TRAP and MVA ME-TRAP

Who this might be right for
Malaria
University of Oxford 39
Large-scale testing (Phase 3)Study completedNCT00453570
What this trial is testing

Immunogenicity and Safety of Pentaxim as 3 Doses Primary Vaccination Followed by a Booster Dose at 18 Months

Who this might be right for
DiphtheriaTetanusHaemophilus Influenzae Type b+2 more
Sanofi 792
Large-scale testing (Phase 3)Study completedNCT04754594
What this trial is testing

To Evaluate the Safety, Tolerability, and Immunogenicity of BNT162b2 Against COVID-19 in Healthy Pregnant Women 18 Years of Age and Older

Who this might be right for
SARS-CoV-2 InfectionCOVID-19Maternal Immunization
BioNTech SE 726
Early research (Phase 1)UnknownNCT00353756
What this trial is testing

Phase 1 Study of Safety and Biological Effects of C326, an Inhibitor of IL-6, in Crohn's Disease

Who this might be right for
Crohn's Disease
Avidia 52
Large-scale testing (Phase 3)Study completedNCT06120751
What this trial is testing

A Clinical Trial to Evaluate the Safety and Immunogenicity of a Single Dose of Adsorbed Tetanus Vaccine in a Population Aged 18 Years and Over

Who this might be right for
Tetanus
CanSino Biologics Inc. 1,000
Large-scale testing (Phase 3)Study completedNCT00322231
What this trial is testing

An Investigational Zoster Vaccine, in Subjects With a History of Herpes Zoster (V211-014)

Who this might be right for
Herpes Zoster
Merck Sharp & Dohme LLC 101
Testing effectiveness (Phase 2)Study completedNCT00924170
What this trial is testing

Phase II Trial of LMB-2, Fludarabine and Cyclophosphamide for Adult T-Cell Leukemia

Who this might be right for
Adult T-Cell Leukemia (ATL)
National Cancer Institute (NCI) 18
Large-scale testing (Phase 3)Study completedNCT06374394
What this trial is testing

A Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a COVID-19 mRNA Vaccine in Adults Aged 50 Years and Above

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 841
Large-scale testing (Phase 3)Study completedNCT01341639
What this trial is testing

Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 3, 4 and 12 Months (V419-007)

Who this might be right for
Bacterial InfectionsVirus Diseases
MCM Vaccines B.V. 1,250
Early research (Phase 1)UnknownNCT03789539
What this trial is testing

Reactogenicity, Safety and Immunogenicity of an Universal Influenza Vaccine Uniflu

Who this might be right for
Safety Issues
VA Pharma Limited Liability Company 54
Early research (Phase 1)Study completedNCT03583606
What this trial is testing

A Trial to Evaluate the Safety and Systems Biology Response of Ebolavirus Zaire Vaccine (ChAd3-EBO-Z)

Who this might be right for
Ebola DiseaseImmunisation
National Institute of Allergy and Infectious Diseases (NIAID) 61
Next Page